Pancreatic Cancer Research

ResearcherIndiana University IndianapolisActive in the last 2 years

Xiumei Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7306-0288; OpenAlex author ID A5087314156. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 3

  1. Isopentyl-Deoxynboquinone Induces Mitochondrial Dysfunction and G2/M Phase Cell Cycle Arrest to Selectively Kill NQO1-Positive Pancreatic Cancer Cells. Last author DOI 10.1089/ars.2022.0224↗
  2. Critical Role of Novel O-GlcNAcylation of S550 and S551 on the p65 Subunit of NF-κB in Pancreatic Cancer. Co-author DOI 10.3390/cancers15194742↗
  3. Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer. First author DOI 10.1002/jso.24624↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yingchun Liu · 1 shared paper, 2024 · strength 0.19
  2. Lingxiang Jiang · 1 shared paper, 2024 · strength 0.19
  3. Ahmad R. Safa · 1 shared paper, 2023 · strength 0.18
  4. Yunlong Liu · 1 shared paper, 2023 · strength 0.18
  5. Aishat Motolani · 1 shared paper, 2023 · strength 0.18
  6. Tao Lu · 1 shared paper, 2023 · strength 0.18
  7. Molly A. Silvers · 1 shared paper, 2017 · strength 0.06
  8. Muhammad Shaalan Beg · 1 shared paper, 2017 · strength 0.06
  9. Matthew E. Merritt · 1 shared paper, 2017 · strength 0.06
  10. David A. Boothman · 1 shared paper, 2017 · strength 0.06
  11. Daniel A. Laheru · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.